-
Product Insights
NewAdenosine Receptor A1 – Drugs In Development, 2024
The Adenosine Receptor A1 pipeline drugs market research report outlays comprehensive information on the Adenosine Receptor A1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Oncology, and Respiratory which include indications of Parkinson's Disease, Alzheimer's Disease, Cardiac Arrest, Congestive Heart Failure (Heart Failure), Solid Tumor, Unspecified Cancer, Asthma, and Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewInterleukin 23 Receptor – Drugs In Development, 2024
The Interleukin 23 Receptor pipeline drugs market research report outlays comprehensive information on the Interleukin 23 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Gastrointestinal, Infectious Disease, and Musculoskeletal Disorders which include indications of Psoriasis, Plaque Psoriasis (Psoriasis Vulgaris), Crohn's Disease (Regional Enteritis), Colitis, Coronavirus Disease 2019 (COVID-19), and Psoriatic Arthritis. It also reviews key...
-
Product Insights
NewCaspase 3 – Drugs In Development, 2024
The Caspase 3 pipeline drugs market research report outlays comprehensive information on the Caspase 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Infectious Disease, and Immunology which include indications of Oncology, Prostate Cancer, Alzheimer's Disease, Parkinson's Disease, Zika Virus Infections, Psoriasis, and Rheumatoid Arthritis. It also reviews key players involved in Caspase...
-
Product Insights
NewArachidonate 5 Lipoxygenase – Drugs In Development, 2024
The Arachidonate 5 Lipoxygenase pipeline drugs market research report outlays comprehensive information on the Arachidonate 5 Lipoxygenase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Immunology, Central Nervous System, and Dermatology which include indications of Asthma, Chronic Obstructive Pulmonary Disease (COPD), Inflammation, Alzheimer's Disease, Parkinson's Disease, and Atopic Dermatitis (Atopic Eczema). It also reviews key players...
-
Product Insights
NewCalpain 1 Catalytic Subunit – Drugs In Development, 2024
The Calpain 1 Catalytic Subunit pipeline drugs market research report outlays comprehensive information on the Calpain 1 Catalytic Subunit targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Central Nervous System, Gastrointestinal, and Infectious Disease which include indications of Ophthalmology, Glaucoma, Alzheimer's Disease, Pain, Liver Fibrosis, and Coronavirus Disease 2019 (COVID-19) Pneumonia. It also reviews key players...
-
Product Insights
NewCoagulation Factor XII – Drugs In Development, 2024
The Coagulation Factor XII pipeline drugs market research report outlays comprehensive information on the Coagulation Factor XII targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Immunology, Central Nervous System, and Infectious Disease which include indications of Thrombosis, Thromboembolic Disease, Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency), Inflammation, Intracerebral Hemorrhage, and Infectious Disease. It also reviews...
-
Product Insights
NewGlutaminyl Peptide Cyclotransferase – Drugs In Development, 2024
The Glutaminyl Peptide Cyclotransferase pipeline drugs market research report outlays comprehensive information on the Glutaminyl Peptide Cyclotransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Gastrointestinal, and Mouth and Dental Disorders which include indications of Unspecified Cancer, Oncology, Alzheimer's Disease, Huntington Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Periodontal Disease, and Periodontitis. It also reviews...
-
Product Insights
NewAlpha 1 Antitrypsin – Drugs In Development, 2024
The Alpha 1 Antitrypsin pipeline drugs market research report outlays comprehensive information on the Alpha 1 Antitrypsin targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Genetic Disorders, Respiratory, Immunology, and Gastrointestinal which include indications of Alpha-1 Antitrypsin Deficiency (A1AD), Charcot-Marie-Tooth Disease, Bronchiectasis, Emphysema, Graft Versus Host Disease (GVHD), Lung Transplant Rejection, Liver Diseases, and Eosinophilic Esophagitis. It...
-
Product Insights
NewStimulator Of Interferon Genes Protein – Drugs In Development, 2024
The Stimulator Of Interferon Genes Protein pipeline drugs market research report outlays comprehensive information on the Stimulator Of Interferon Genes Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Central Nervous System which include indications of Solid Tumor, Unspecified Cancer, Inflammation, Autoimmune Disorders, Coronavirus Disease 2019 (COVID-19), Hepatitis B, Parkinson's Disease, and...
-
Product Insights
NewCoagulation Factor VIII – Drugs In Development, 2024
The Coagulation Factor VIII pipeline drugs market research report outlays comprehensive information on the Coagulation Factor VIII targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Hemophilia A (Factor VIII Deficiency), Von Willebrand Disease (vWD), Venous Thromboembolism, Acute Ischemic Stroke, Alzheimer's Disease, Amyotrophic Lateral Sclerosis,...